June 16 (Reuters) - U.S. drugmaker Eli Lilly LLY.N said on Monday it will offer the higher dose versions of its popular weight-loss drug Zepbound on its website LillyDirect.
The company said 12.5 milligrams and 15 mg doses of the drug will be available for $499 per month on the website with shipments to patients beginning in early August.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Shailesh Kuber)
((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。